病例报告:一个儿科持续性耐火性ITP病例,该病例对AVATROMBOPAG有反应
Antonella Sau1, Gianfranco Di Prinzio1, Daniela Onofrillo1
1Department of Hematology and Oncology, Santo Spirito Hospital, Pescara, Italy.
Frontiers in immunology
|April 30, 2025
概括
免疫性血小板缺血 (ITP) 是一种罕见的出血障碍. 一个患有耐火性ITP的年轻女孩,对标准治疗无反应,经历了AVATROMBOPAG的显著改善,AVATROMBOPAG是一种新型的血栓形成素受体激动剂.
科学领域:
- 血液学 血液学 血液学
- 免疫学 免疫学 免疫学
- 儿科 儿科 儿科
背景情况:
- 免疫性血小板缺血 (ITP) 是一种罕见的自身免疫性疾病.
- 由于免疫媒介的血小板破坏,血小板数量较低的特征.
- 像皮质类固醇和IVIG这样的标准治疗对所有患者都不有效.
研究的目的:
- 在儿科患者中报告一种耐火性ITP病例.
- 为了评估AVATROMBOPAG在不响应ITP病例中的疗效.
- 突出AVATROMBOPAG作为耐火性ITP的潜在治疗选择.
主要方法:
- 一个6岁女孩患有耐火性ITP的案例报告.
- 记录了对传统疗法 (皮质类固醇,IVIG) 的反应失败.
- 启动和监测阿瓦特罗姆波巴格治疗.
主要成果:
- 患者在服用阿瓦特罗姆博帕格后表现出显著的临床改善.
- 在这种耐火性ITP病例中,Avatrombopag有效地增加了血小板计数.
- 在儿科患者中证明了阿瓦特罗姆博帕格的安全性和有效性.
结论:
- 阿瓦特罗姆波帕格 (Avatrombopag) 是一种血栓形成素受体激动剂,它对治疗儿童中耐火性ITP具有前景.
- 这一案例表明,阿瓦特罗姆波巴 (avatrombopag) 是适用于对标准治疗无反应的儿科患者的可行的治疗选择.
- 需要进一步的研究来证实阿瓦特罗姆波帕格在儿科耐火性ITP治疗中的作用.
关键词:
这就是Avatrombopag.孩子们的孩子们的孩子们的孩子们.免疫性血小板缺血症 (ITP) 是一种疾病.持续性或慢性免疫性血小板缺血症.血小板 血小板 血小板是什么?血栓形成素受体 (TPOr) 激活剂的激活剂.更多相关视频
10:31Surgical Angiogenesis in Porcine Tibial Allotransplantation: A New Large Animal Bone Vascularized Composite Allotransplantation Model
Published on: August 13, 2017
7.6K
10:15Conditional Reprogramming of Pediatric Human Esophageal Epithelial Cells for Use in Tissue Engineering and Disease Investigation
Published on: March 22, 2017
6.9K
相关概念视频
01:23Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists
613
Prostacyclin receptor agonists are a class of therapeutic agents integral to managing pulmonary arterial hypertension (PAH). These drugs operate by mimicking the action of prostaglandin I2, or PGI2, a naturally occurring compound in the body.
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
613
01:29Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care
749
Diagnosing Pulmonary EmbolismDiagnosing pulmonary embolism (PE) involves clinical assessment and advanced imaging tests. The preferred diagnostic tool is the spiral (helical) CT scan or CT angiography (CTA), which uses intravenous contrast media to visualize the pulmonary vasculature and identify emboli.A ventilation-perfusion (V/Q) scan is an alternative for patients unable to receive contrast media. This scan includes both perfusion and ventilation scanning. Perfusion scanning involves...
749